{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:04:30Z","timestamp":1794960270521,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":68,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pilgrim Trust and Mundipharma International Limited"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health"},{"name":"Maudsley NHS Foundation Trust and King's College London"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.drugalcdep.2018.03.057","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:01:09Z","timestamp":1527256869000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin"],"prefix":"10.1016","volume":"189","author":[{"given":"Joanne","family":"Neale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte N.E.","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-5983","authenticated-orcid":false,"given":"Rebecca","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-2725","authenticated-orcid":false,"given":"John","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0005","series-title":"Feminism, Science and the Philosophy of Science","first-page":"161","article-title":"Meeting the universe halfway: realism and social constructivism without contradiction","author":"Barad","year":"1996"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0010","series-title":"Meeting the Universe Half Way \u2013 Quantum Physics and Entanglement of Matter and Meaning","author":"Barad","year":"2007"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0015","series-title":"The Posthuman","author":"Braidotti","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugpo.2017.08.006","article-title":"From mundane medicines to euphorigenic drugs: how pharmaceutical pleasures are initiated, foregrounded, and made durable","volume":"49","author":"Bundy","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0025","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/13543784.16.8.1285","article-title":"Sustained-release naltrexone: novel treatment for opioid dependence","volume":"16","author":"Comer","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0030","series-title":"New materialisms. Ontology, Agency, and Politics","first-page":"1","article-title":"Introducing the new materialisms","author":"Coole","year":"2010"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0035","series-title":"A Thousand Plateaus: Capitalism and Schizophrenia","author":"Deleuze","year":"1988"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200220003-00001","article-title":"The value of improving the productivity of the drug development process. Faster times and better decisions","volume":"20","author":"DiMasi","year":"2002","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0045","series-title":"Substance and Substitution: Methadone Subjects in Liberal Societies","author":"Fraser","year":"2008"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1363459315615393","article-title":"Health sociology from post-structuralism to the new materialisms","volume":"20","author":"Fox","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0055","series-title":"The SAGE Encyclopedia of Research Methods","article-title":"New materialism","author":"Fox","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0060","series-title":"Drug Safety Evaluation","author":"Gad","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1783\/147118908786000497","article-title":"Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods","volume":"34","author":"Glasier","year":"2008","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0306312702032001005","article-title":"Methadone: six effects in search of a substance","volume":"32","author":"Gomart","year":"2002","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0075","series-title":"Cyborgs, Simians and Women","author":"Haraway","year":"1991"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2015.03.002","article-title":"Conceptualizing risk and effectiveness: a qualitative study of women\u2019s and providers\u2019 perceptions of nonsurgical female permanent contraception","volume":"92","author":"Harrington","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0085","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","article-title":"Methadone diversion as a protective strategy: the harm reduction potential of\u2019 generous constraints","volume":"24","author":"Harris","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10826084.2017.1385633","article-title":"At the expense of a life: Race, class, and the meaning of buprenorphine in pharmaceuticalized \u2018care\u2019","volume":"53","author":"Hatcher","year":"2018","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0253-7176.112194","article-title":"Long-acting preparations in substance abuse management: a review and update","volume":"35","author":"Hegde","year":"2013","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/16066359409005200","article-title":"The patient\u2019s charter: drug users\u2019 views on the \u2018ideal\u2019 methadone programme","volume":"1","author":"Jones","year":"1994","journal-title":"Addict. Res."},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0105","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.drugpo.2013.05.007","article-title":"Categorising methadone: addiction and analgesia","volume":"24","author":"Keene","year":"2013","journal-title":"Int. J. Drug. Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0110","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3109\/10826089909039442","article-title":"Active heroin injectors\u2019 perceptions and use of methadone maintenance treatment: cynical performance or self-prescribed risk reduction?","volume":"34","author":"Koester","year":"1999","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0115","series-title":"Reassembling the Social: An Introduction to Actor-Network-Theory","author":"Latour","year":"2005"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0120","series-title":"Actor Network Theory and after","first-page":"1","article-title":"After ANT: complexity, naming and topology","author":"Law","year":"1999"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0125","series-title":"Naturalistic Inquiry","author":"Lincoln","year":"1985"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0130","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.drugpo.2013.08.006","article-title":"Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients","volume":"24","author":"Monaghan","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02791072.1992.10471646","article-title":"Living with the dirty secret: problems of disclosure for methadone maintenance clients","volume":"24","author":"Murphy","year":"1992","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09687639809035769","article-title":"Drug users\u2019 views of prescribed methadone","volume":"5","author":"Neale","year":"1998","journal-title":"Drugs Educ. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/oxfordjournals.bjsw.a011422","article-title":"Understanding drug using clients\u2019 views of substitute prescribing","volume":"29","author":"Neale","year":"1999","journal-title":"Br. J. Soc. Work"},{"issue":"0","key":"10.1016\/j.drugalcdep.2018.03.057_bib0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0955-3959(99)00016-X","article-title":"Drug users\u2019 views of substitute prescribing conditions","volume":"1","author":"Neale","year":"1999","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.drugpo.2013.08.003","article-title":"Opioid pharmacotherapy: treatment, regimes, constructions and control","volume":"24","author":"Neale","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0160","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/add.13314","article-title":"Iterative categorisation (IC): a systematic technique for analysing qualitative data","volume":"111","author":"Neale","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0165","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1360-0443.2005.01230.x","article-title":"Qualitative research methods within the addictions","volume":"100","author":"Neale","year":"2005","journal-title":"Addiction"},{"issue":"08","key":"10.1016\/j.drugalcdep.2018.03.057_bib0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/add.12051","article-title":"Addiction journal is committed to publishing qualitative research","volume":"1","author":"Neale","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1363459312451182","article-title":"I just want to be normal\u201d: an analysis of discourses of normality among recovering heroin users","volume":"17","author":"Nettleton","year":"2013","journal-title":"Health"},{"issue":"32","key":"10.1016\/j.drugalcdep.2018.03.057_bib0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1192\/bjp.132.5.473","article-title":"The effects of methadone maintenance with opioid takers: a review and some findings from one British city","volume":"1","author":"Paxton","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0185","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.drugpo.2013.09.009","article-title":"Prescribing opioid pharmacotherapy in the context of the \u201cnew recovery\u201d: physicians\u2019 perspectives of rhetoric and reality","volume":"24","author":"Radcliffe","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0190","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenophine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0195","first-page":"325","article-title":"Drug misusers\u2019 experiences and opinions of community pharmacists and community pharmacy services","volume":"257","author":"Sheridan","year":"1996","journal-title":"Pharm. J."},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1360-0443.2006.01348.x","article-title":"An injection depot formulation of buprenorphine: extended biodelivery and effects","volume":"101","author":"Sigmon","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/add.13539","article-title":"Food and drug administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential","volume":"112","author":"Sigmon","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0210","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0215","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.drugpo.2013.05.005","article-title":"What is low threshold methadone maintenance treatment?","volume":"24","author":"Strike","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0220","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.drugpo.2013.04.010","article-title":"Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the \u2018small stuff\u2019 in a liberal paradise","volume":"24","author":"Treloar","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0038038507076619","article-title":"Methadone maintenance treatment and making up people","volume":"41","author":"valentine","year":"2007","journal-title":"Sociology"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0230","series-title":"Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV\/AIDS Prevention","author":"WHO\/UNODC\/UNAIDS","year":"2004"},{"key":"10.1016\/j.drugalcdep.2018.03.057_bib0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2307\/1966670","article-title":"Assessing the acceptability of NORPLANT implants in four countries: findings from focus group research","volume":"21","author":"Zimmerman","year":"1990","journal-title":"Stud. Fam. Plan."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:54:10Z","timestamp":1759827250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618302898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":47,"alternative-id":["S0376871618302898"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.057","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 King's College London. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}